© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent

M&A in 2026: time to summon up the blood


Country’s IPO market is returning after lull caused by political instability
◆ Why Europe's corporate bond market is on a roll ◆ Reverse Yankees, hot hybrids and huge size with more to come ◆ Europe's stock exchanges' attempts to drum up more IPOs
Hope SIU could boost retail investment flows
Shares in Optasia have risen 5% after Africa's largest listing this year
More articles/Ad

More articles/Ad

More articles

  • Mister Spex, the German eyewear retailer, remained buoyant in trading on Friday after its €326m IPO on the Frankfurt Stock Exchange.
  • Xpeng bagged HK$14bn ($1.8bn) this week from the first secondary listing in Hong Kong by a Chinese electric vehicle maker.
  • Equity capital markets are bracing for an influx of Russian IPOs in the autumn, following a slight easing of tensions between the US and Russia. However, not only is the threat of further sanctions still present, but Russian IPO candidates will also be heading into an increasingly crowded and difficult market, writes Aidan Gregory.
  • The possible flotation of a Russian hospitals group is being billed as a revival of the country’s IPO market, with more deals to follow. Bankers pointed to the recent US-Russian summit in Switzerland as cause for optimism but investors should remain as sceptical as they appear to be about the rest of the IPO market.
  • Bulgarian animal healthcare company Huvepharma has become the latest casualty in an IPO market oversaturated with supply.
  • UBS has appointed global heads of equity capital markets for the first time in almost two years as the Swiss bank eyes opportunities in a booming IPO market.